AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy
Authors: Koukourakis, MI Giatromanolaki, A Sivridis, E Simopoulos, K Pastorek, J Wykoff, CC Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy, CLIN CANC R, 7(11), 2001, pp. 3399-3403
Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer
Authors: Kakolyris, S Giatromanolaki, A Koukourakis, M Powis, G Souglakos, J Sivridis, E Georgoulias, V Gatter, KC Harris, AL
Citation: S. Kakolyris et al., Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer, CLIN CANC R, 7(10), 2001, pp. 3087-3091
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
Authors: Chia, SK Wykoff, CC Watson, PH Han, C Leek, RD Pastorek, J Gatter, KC Ratcliffe, P Harris, AL
Citation: Sk. Chia et al., Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma, J CL ONCOL, 19(16), 2001, pp. 3660-3668
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/REF-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome
Authors: Koukourakis, MI Giatromanolaki, A Kakolyris, S Sivridis, E Georgoulias, V Funtzilas, G Hickson, ID Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/REF-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome, INT J RAD O, 50(1), 2001, pp. 27-36
Plasminogen activator inhibitor-I as a measure of vascular remodelling in breast cancer
Authors: Fox, SB Taylor, M Grondahl-Hansen, J Kakolyris, S Gatter, KC Harris, AL
Citation: Sb. Fox et al., Plasminogen activator inhibitor-I as a measure of vascular remodelling in breast cancer, J PATHOLOGY, 195(2), 2001, pp. 236-243
The angiogenic pathway 'vascular endothelial growth factor/flk-I (KDR)-receptor' in rheumatoid arthritis and osteoarthritis
Authors: Giatromanolaki, A Sivridis, E Atanassou, N Zois, E Thorpe, PE Brekken, RA Gatter, KC Harris, AL Koukourakis, IM Koukourakis, MI
Citation: A. Giatromanolaki et al., The angiogenic pathway 'vascular endothelial growth factor/flk-I (KDR)-receptor' in rheumatoid arthritis and osteoarthritis, J PATHOLOGY, 194(1), 2001, pp. 101-108
Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
Authors: Koukourakis, MI Giatromanolaki, A Skarlatos, J Corti, L Blandamura, S Piazza, M Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy, CANCER RES, 61(5), 2001, pp. 1830-1832
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenicpathways and independently to poor outcome in non-small cell lung cancer
Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Pastorek, J Wykoff, CC Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenicpathways and independently to poor outcome in non-small cell lung cancer, CANCER RES, 61(21), 2001, pp. 7992-7998
The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma - Prognostic and therapeutic implications
Authors: Giatromanolaki, A Sivridis, E Brekken, R Thorpe, PE Anastasiadis, P Gatter, KC Harris, AL Koukourakis, MI
Citation: A. Giatromanolaki et al., The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma - Prognostic and therapeutic implications, CANCER, 92(10), 2001, pp. 2569-2577
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Turley, H Talks, K Pezzella, F Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival, BR J CANC, 85(6), 2001, pp. 881-890
The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells
Authors: Turley, H Wu, L Canamero, M Gatter, KC Hickson, ID
Citation: H. Turley et al., The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells, BR J CANC, 85(2), 2001, pp. 261-265
More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
Authors: Fox, SB Gatter, KC Leek, RD Harris, AL Chew, KL Mayall, BH Moore, DH
Citation: Sb. Fox et al., More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma, J NAT CANC, 92(2), 2000, pp. 161-162
c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer
Authors: Koukourakis, MI Giatromanolaki, A Guddo, F Kaklamanis, L Vignola, M Kakolyris, S Turley, H Georgoulias, V Bonsignore, G Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer, J IMMUNOTH, 23(1), 2000, pp. 104-114
Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways
Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E O'Byrne, K Cox, G Thorpe, PE Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways, CLIN CANC R, 6(5), 2000, pp. 1917-1921
Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy
Authors: Koukourakis, MI Giatromanolaki, A Fountzilas, G Sivridis, E Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy, CLIN CANC R, 6(2), 2000, pp. 381-389
Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence
Authors: Kakolyris, SA Kaklamanis, LG Koukourakis, MJ Giatromanolaki, A Rousomoustakaki, M Souglakos, JC Reppa, DK Georgoulias, VA Gatter, KC Harris, AL
Citation: Sa. Kakolyris et al., Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence, ONCOL RES, 12(4), 2000, pp. 203-208
Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer
Authors: Giatromanolaki, A Koukourakis, MI Stathopoulos, GP Kapsoritakis, A Paspatis, G Kakolyris, S Sivridis, E Georgoulias, V Harris, AL Gatter, KC
Citation: A. Giatromanolaki et al., Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer, ONCOL RES, 12(1), 2000, pp. 33-41
Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas
Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Thorpe, PE Brekken, RA Konstantinos, S Fountzilas, G Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas, CLIN EXP M, 18(4), 2000, pp. 313-319
Evidence for novel non-angiogenic pathway in breast-cancer metastasis
Authors: Pezzella, F Manzotti, M Di Bacco, A Viale, G Nicholson, AG Price, R Ratcliffe, C Pastorino, U Gatter, KC Harris, AL Altman, DG Pilotti, S Veronesi, U
Citation: F. Pezzella et al., Evidence for novel non-angiogenic pathway in breast-cancer metastasis, LANCET, 355(9217), 2000, pp. 1787-1788
Role of angiogenesis in benign, premalignant and malignant vulvar lesions
Authors: MacLean, AB Reid, WMN Rolfe, KJ Gammell, SJ Pugh, HEJ Gatter, KC Fong, ACWT Crow, JC Perrett, CW
Citation: Ab. Maclean et al., Role of angiogenesis in benign, premalignant and malignant vulvar lesions, J REPRO MED, 45(8), 2000, pp. 609-612
'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer
Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E O'Byrne, K Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer, J PATHOLOGY, 192(2), 2000, pp. 140-149
Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome
Authors: Turner, HE Nagy, Z Gatter, KC Esiri, MM Harris, AL Wass, JAH
Citation: He. Turner et al., Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome, J ENDOCR, 165(2), 2000, pp. 475-481
Thymidine phosphorylase expression in normal and hyperplastic endometrium
Authors: Sivridis, E Giatromanolaki, A Koukourakis, MI Bicknell, R Harris, AL Gatter, KC
Citation: E. Sivridis et al., Thymidine phosphorylase expression in normal and hyperplastic endometrium, J CLIN PATH, 53(9), 2000, pp. 704-708
Angiogenesis in pituitary adenomas and the normal pituitary gland
Authors: Turner, HE Nagy, Z Gatter, KC Esiri, MM Harris, AL Wass, JAH
Citation: He. Turner et al., Angiogenesis in pituitary adenomas and the normal pituitary gland, J CLIN END, 85(3), 2000, pp. 1159-1162
The Bloom's syndrome gene product interacts with topoisomerase III
Authors: Wu, L Davies, SL North, PS Goulaouic, H Riou, JF Turley, H Gatter, KC Hickson, ID
Citation: L. Wu et al., The Bloom's syndrome gene product interacts with topoisomerase III, J BIOL CHEM, 275(13), 2000, pp. 9636-9644
Risultati: 1-25 | 26-43